Keyphrases
Psoriasis
100%
Cardiovascular Disease
61%
Inflammation
58%
Vascular Inflammation
51%
Neutrophil-to-lymphocyte Ratio
45%
Blood Samples
43%
Cardiovascular Risk
34%
Subclinical Atherosclerosis
31%
Bone Marrow
31%
Spleen
31%
Transcriptomic Signature
27%
Blood Transcriptomics
27%
Neutrophils
27%
Psoriasis Disease
27%
PET-computed Tomography
27%
Definitive Therapy
27%
Gestational Diabetes Mellitus
27%
Lung Cancer Patients
27%
Computed Tomography
27%
Randomized Controlled Trial
27%
Patient Treatment
27%
Curative Intent
27%
Hepatic Fat Content
27%
Non-alcoholic Fatty Liver Disease (NAFLD)
27%
A1 Receptor
27%
Randomized Placebo-controlled Trial
27%
Glucagon-like
27%
Receptor Agonist
27%
Liquid Biopsy
27%
Adipose Tissue
27%
Liraglutide
27%
Atherosclerotic Cardiovascular Disease (ASCVD)
20%
18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
Growth Differentiation factor-15 (GDF-15)
20%
Carotid Intima-media Thickness (cIMT)
19%
Positron Emission Tomography-computed Tomography (PET-CT)
18%
Lung Cancer Surveillance
13%
Differentially Expressed Genes
13%
Lung Cancer
13%
Cardiovascular Therapy
13%
Tumor Necrosis Factor-α
13%
Impact on Patients
13%
Relapse Risk
13%
Follow-up Control
13%
Randomized Phase III Trial
13%
Statin Therapy
13%
Treatment Quality
13%
Circulating Tumor DNA (ctDNA)
13%
Follow-up Program
13%
Quality of Life
13%
Medicine and Dentistry
Psoriasis
81%
Cardiovascular Disease
57%
Adipose Tissue
46%
Vasculitis
44%
Positron Emission Tomography-Computed Tomography
33%
Biological Marker
27%
Cardiovascular Risk
27%
Atherosclerosis
27%
Case-Control Study
27%
Arm
27%
Randomized Controlled Trial
27%
Lung Cancer
27%
Computer Assisted Tomography
27%
Positron Emission Tomography
27%
Liquid Biopsy
27%
Fluorodeoxyglucose F 18
27%
Neutrophil
18%
Lymphocyte
18%
Intima-Media Thickness
14%
Growth Differentiation Factor 15
13%
Carotid Artery
12%
Statin
12%
Disease
11%
Isotopes of Calcium
9%
Tumor Necrosis Factor
9%
Proteomics
8%
Ascending Aorta
8%
Skin Biopsy
7%
Lung Cancer Diagnostics
6%
Cancer Diagnosis
6%
Circulating Tumor DNA
6%
Quality of Life
6%
DNA Determination
6%
Tissue (Anatomy)
5%
Body Mass Index
5%
C Reactive Protein
5%
Ultrasonography
5%
Immunology and Microbiology
Adipose Tissue
54%
Neutrophil
54%
Vasculitis
53%
Lymphocyte
40%
Positron Emission Tomography-Computed Tomography
37%
Transcriptomics
32%
Atherosclerosis
30%
Body Weight
27%
Agonist
27%
Growth Differentiation Factor 15
20%
Carotid Artery
19%
Tumor Necrosis Factor
13%
Blood Sampling
13%
Ascending Aorta
12%
Blood Plasma
12%
Metagenomics
10%
RNA Sequence
8%
C-Reactive Protein
8%
Coronary Artery
6%
Degranulation
6%
Exercise
5%
Feces
5%
Mass Cytometry
5%
Vascular Tissue
5%
Aortic Arch
5%
Microbiome
5%
Mental Health
5%
Body Mass
5%
Gut Microbiome
5%
